Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

143.96
Delayed Data
As of 4:14pm ET
 +1.14 / +0.80%
Today’s Change
96.18
Today|||52-Week Range
149.34
+17.66%
Year-to-Date
Abbvie/Bristol-Myers Inks Deal to Develop Therapeutic Cancer
11:30am / Zacks.com - Paid Partner Content
Keryx Biopharmaceuticals, Inc. (KERX) Catches Eye: Stock Jumps 5.9%
Sep 18 / Zacks.com - Paid Partner Content
The Medicines Co. Continues to Focus on Pipeline Development
Sep 22 / Zacks.com - Paid Partner Content
Why Alexion Pharmaceuticals (ALXN) Could Beat Earnings Estimates Again
Sep 18 / Zacks.com - Paid Partner Content
Bayer (BAYRY) Focuses on Pipeline Development & Acquisitions
Sep 22 / Zacks.com - Paid Partner Content
Intercept Pharmaceuticals (ICPT) in Focus: Stock Moves 8.6% Higher
Sep 18 / Zacks.com - Paid Partner Content
Dr. Reddy's Laboratories (RDY) Surges: Stock Moves 5.7% Higher
Sep 22 / Zacks.com - Paid Partner Content
Abeona Therapeutics (ABEO) Surges: Stock Moves 22.9% Higher
Sep 18 / Zacks.com - Paid Partner Content
Werner Enterprises, Cott, Akari Therapeutics, and Alexion highlighted as Zacks Bull a...
Sep 22 / Zacks.com - Paid Partner Content
Synthetic Biologics (SYN) in Focus: Stock Moves 7.7% Higher
Sep 18 / Zacks.com - Paid Partner Content
Ardsley Advisory Partners Buys Alexion Pharmaceuticals Inc, New Residential Investmen...
Sep 21 / GuruFocus News - Paid Partner Content
Pfizer Xtandi Succeeds in Early Stage Prostate Cancer Study
Sep 15 / Zacks.com - Paid Partner Content
Akari Therapeutics (AKTX) Stock is Skyrocketing Over 60% Today: Here's Why
Sep 21 / Zacks.com - Paid Partner Content
Strength Seen in Halozyme Therapeutics (HALO): Stock Soars 21.2%
Sep 15 / Zacks.com - Paid Partner Content
Alnylam/Sanofi's RNAi Drug Meets Endpoint in Study, Stock Up
Sep 21 / Zacks.com - Paid Partner Content
4 Biotech Stocks That Show Promise on Sustainable Growth
Sep 14 / Zacks.com - Paid Partner Content
Karyopharm's Liposarcoma Candidate Superior in Phase II Study
Sep 21 / Zacks.com - Paid Partner Content
Glaxo's Shingles Candidate Gets Positive FDA Committee Vote
Sep 14 / Zacks.com - Paid Partner Content
Alnylam Pharmaceuticals (ALNY) Soars: Stock Adds 51.7% in Session
Sep 21 / Zacks.com - Paid Partner Content
Alexion (ALXN) Reports Interim Results for Soliris Study
Sep 14 / Zacks.com - Paid Partner Content
Novartis Poised to Grow on Oncology Portfolio & Biosimilars
Sep 20 / Zacks.com - Paid Partner Content
Roche (RHHBY) Announces Data on Respiratory Drug Esbriet
Sep 13 / Zacks.com - Paid Partner Content
ProQR's Genetic Disorder Candidate Gets Orphan Drug Status
Sep 20 / Zacks.com - Paid Partner Content
Alexion to Restructure Operations, to Lower Headcount by 20%
Sep 13 / Zacks.com - Paid Partner Content
Teva/Nuvelution to Speed Up Development of Austedo in US
Sep 20 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Alexion to Cut Jobs, Streamline Operations, Kura Up on Cancer ...
Sep 13 / Zacks.com - Paid Partner Content
Epizyme (EPZM) Looks Good: Stock Adds 7.8% in Session
Sep 20 / Zacks.com - Paid Partner Content
Achillion's HCV Partnership with J&J Terminated, Stock Falls
Sep 12 / Zacks.com - Paid Partner Content
Alkermes' ARISTADA Shows Better Results to Treat Schizophrenia
Sep 19 / Zacks.com - Paid Partner Content
AstraZeneca's Asthma Candidate Shows Promising Results
Sep 12 / Zacks.com - Paid Partner Content
Pluristem's Ischemia Candidate Gets Fast Track Designation
Sep 19 / Zacks.com - Paid Partner Content
Pfizer Lung Cancer Drug's Overall Survival Data Unfavorable
Sep 12 / Zacks.com - Paid Partner Content
Clovis Oncology (CLVS) in Focus: Stock Moves 10.5% Higher
Sep 19 / Zacks.com - Paid Partner Content
AstraZeneca's Lung Cancer Study Data Promising, Shares Spike
Sep 11 / Zacks.com - Paid Partner Content
Axovant Sciences Ltd. (AXON) Jumps: Stock Rises 7.2%
Sep 19 / Zacks.com - Paid Partner Content
Regeneron/Sanofi's Dupixent Asthma Study Meets Endpoints
Sep 11 / Zacks.com - Paid Partner Content
J&J's (JNJ) Psoriasis Drug Guselkumab Gets CHMP Nod in EU
Sep 18 / Zacks.com - Paid Partner Content
5 Top-Ranked Biotech Stocks to Buy Right Now
Sep 11 / Zacks.com - Paid Partner Content
Glaxo's Triple Therapy COPD Inhaler Gets CHMP Nod in the EU
Sep 18 / Zacks.com - Paid Partner Content